Phenominer Database Results (36 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 5.17 uV 1.18 3.91 electroretinography cornea 0.0 subretinal injection 2 days CHPG a-wave amplitude ERG 108464 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 11.68 uV 2.42 8.03 electroretinography cornea 0.0 subretinal injection 2 days CHPG a-wave amplitude ERG 108465 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 71.37 uV 8.23 27.3 electroretinography cornea 0.0 subretinal injection 2 days CHPG a-wave amplitude ERG 108466 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 6.38 uV 1.4 3.43 electroretinography cornea 0.0 subretinal injection 30 min CHPG a-wave amplitude ERG 108440 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 25.21 uV 4.23 10.36 electroretinography cornea 0.0 subretinal injection 30 min CHPG a-wave amplitude ERG 108441 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 88.5 uV 12.52 30.67 electroretinography cornea 0.0 subretinal injection 30 min CHPG a-wave amplitude ERG 108442 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 56.16 uV 17.2 42.13 electroretinography cornea 0.0 subretinal injection 30 min CHPG b-wave amplitude ERG 108452 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 440.0 uV 43.67 106.97 electroretinography cornea 0.0 subretinal injection 30 min CHPG b-wave amplitude ERG 108454 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 44.02 uV 13.47 44.67 electroretinography cornea 0.0 subretinal injection 2 days CHPG b-wave amplitude ERG 108476 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 389.91 uV 52.11 172.83 electroretinography cornea 0.0 subretinal injection 2 days CHPG b-wave amplitude ERG 108480 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 15.46 uV 4.1 10.04 electroretinography cornea 0.0 subretinal injection 10 days CHPG a-wave amplitude ERG 108488 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 485.67 uV 73.15 179.18 electroretinography cornea 0.0 subretinal injection 10 days CHPG b-wave amplitude ERG 108503 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 104.17 uV 12.63 41.89 electroretinography cornea 0.0 subretinal injection 2 days CHPG a-wave amplitude ERG 108467 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 351.91 uV 47.74 158.34 electroretinography cornea 0.0 subretinal injection 2 days CHPG b-wave amplitude ERG 108479 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 410.09 uV 45.37 150.48 electroretinography cornea 0.0 subretinal injection 2 days CHPG b-wave amplitude ERG 108481 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 80.6 uV 11.3 27.68 electroretinography cornea 0.0 subretinal injection 10 days CHPG a-wave amplitude ERG 108490 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 188.33 uV 15.56 38.11 electroretinography cornea 0.0 subretinal injection 10 days CHPG a-wave amplitude ERG 108493 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 71.98 uV 18.54 45.41 electroretinography cornea 0.0 subretinal injection 10 days CHPG b-wave amplitude ERG 108500 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 385.17 uV 61.99 151.84 electroretinography cornea 0.0 subretinal injection 10 days CHPG b-wave amplitude ERG 108501 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 511.83 uV 65.06 159.36 electroretinography cornea 0.0 subretinal injection 10 days CHPG b-wave amplitude ERG 108504 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 155.28 uV 13.68 33.51 electroretinography cornea 0.0 subretinal injection 30 min CHPG a-wave amplitude ERG 108443 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 514.67 uV 47.85 117.21 electroretinography cornea 0.0 subretinal injection 30 min CHPG b-wave amplitude ERG 108455 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 587.83 uV 53.2 130.31 electroretinography cornea 0.0 subretinal injection 30 min CHPG b-wave amplitude ERG 108456 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 579.0 uV 50.99 124.9 electroretinography cornea 0.0 subretinal injection 30 min CHPG b-wave amplitude ERG 108457 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 118.51 uV 12.59 41.76 electroretinography cornea 0.0 subretinal injection 2 days CHPG a-wave amplitude ERG 108468 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 137.5 uV 12.91 42.82 electroretinography cornea 0.0 subretinal injection 2 days CHPG a-wave amplitude ERG 108469 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 166.85 uV 19.57 47.94 electroretinography cornea 0.0 subretinal injection 10 days CHPG a-wave amplitude ERG 108492 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 429.5 uV 66.11 161.94 electroretinography cornea 0.0 subretinal injection 10 days CHPG b-wave amplitude ERG 108502 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 605.83 uV 62.69 153.56 electroretinography cornea 0.0 subretinal injection 10 days CHPG b-wave amplitude ERG 108505 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 201.67 uV 18.19 44.56 electroretinography cornea 0.0 subretinal injection 30 min CHPG a-wave amplitude ERG 108444 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 216.67 uV 19.46 47.67 electroretinography cornea 0.0 subretinal injection 30 min CHPG a-wave amplitude ERG 108445 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 381.17 uV 37.99 93.06 electroretinography cornea 0.0 subretinal injection 30 min CHPG b-wave amplitude ERG 108453 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 270.09 uV 34.35 113.93 electroretinography cornea 0.0 subretinal injection 2 days CHPG b-wave amplitude ERG 108477 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 334.55 uV 43.36 143.81 electroretinography cornea 0.0 subretinal injection 2 days CHPG b-wave amplitude ERG 108478 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 24.73 uV 6.11 14.97 electroretinography cornea 0.0 subretinal injection 10 days CHPG a-wave amplitude ERG 108489 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform 2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 119.33 uV 19.43 47.59 electroretinography cornea 0.0 subretinal injection 10 days CHPG a-wave amplitude ERG 108491 3123